Josh is the Vice President of Product Innovation and Strategy at Slayback Pharma. In this role he will help build a portfolio that will deliver innovative products that meet the evolving needs of the marketplace. He has over 19 years of experience starting with Pharmaceutical Development at Merck Research Laboratories and most recently Global Commercial Lead for Lifecyle Management at Pfizer. Josh holds a BE in Chemical Engineering, MS in Pharmaceutics and an MBA in Corporate Innovation and Leadership from Stevens Institute of Technology.